This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Hold Stericycle (SRCL) Stock for Now
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships that ensure a steady flow of revenues.
Stericycle (SRCL) Gains 3.3% Despite Missing Q2 Estimates
by Zacks Equity Research
Stericycle (SRCL) evidences year-over-year decreases in revenues and earnings in the second quarter of 2023.
Compared to Estimates, Stericycle (SRCL) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Stericycle (SRCL) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Stericycle (SRCL) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of -12.24% and 2.09%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Wall Street Analysts Believe Stericycle (SRCL) Could Rally 25.4%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Stericycle (SRCL) points to a 25.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
SRCL or WCN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SRCL vs. WCN: Which Stock Is the Better Value Option?
Stericycle (SRCL) Gains 9% in the Past 3 Months: Here's How
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships, most of which include long-term contracts ranging from three to five years.
Here's Why You Should Hold Stericycle (SRCL) Stock for Now
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships that ensure a steady flow of revenues.
Stericycle (SRCL) Gains From Acquisitions Despite Forex Woes
by Zacks Equity Research
Stericycle (SRCL) is benefiting from its multi-year business initiative amid a highly competitive market.
Reasons to Retain Stericycle (SRCL) Stock in Your Portfolio
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships that ensure a steady flow of revenues.
Stericycle's (SRCL) Q1 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
Stericycle's (SRCL) first-quarter 2023 revenues increase year over year.
Stericycle (SRCL) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 13.95% and 1.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Stericycle (SRCL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stericycle (SRCL) Stock Drops 3% Since Q4 Earnings Release
by Zacks Equity Research
Stericycle's (SRCL) fourth-quarter 2022 earnings and revenues increase year over year.
Stericycle (SRCL) Matches Q4 Earnings Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 0% and 3.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Stericycle (SRCL) Gains 19% in the Past 3 Months: Here's How
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships, most of which include long-term contracts ranging from three to five years.
Why You Should Retain Stericycle (SRCL) in Your Portfolio Now
by Zacks Equity Research
Stericycle (SRCL) is currently benefiting from its comprehensive multiyear Business Transformation as well as solid liquidity.
Why You Should Retain Stericycle (SRCL) in Your Portfolio Now
by Zacks Equity Research
Stericycle (SRCL) is being aided by a complete multiyear Business Transformation and a solid cash position.
Stericycle (SRCL) Stock Rises 6.6% Since Q3 Earnings Beat
by Zacks Equity Research
Stericycle's (SRCL) third-quarter 2022 earnings and revenues increase year over year.
Stericycle (SRCL) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 10.17% and 2.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
GFL Environmental Inc. (GFL) Q3 Earnings Meet Estimates
by Zacks Equity Research
GFL Environmental Inc. (GFL) delivered earnings and revenue surprises of 0% and 11.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Stericycle (SRCL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons to Retain Stericycle (SRCL) Stock in Your Portfolio
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships in the form of long-term contracts ranging from three to five years.
QRHC or SRCL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
QRHC vs. SRCL: Which Stock Is the Better Value Option?
Stericycle (SRCL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 11.63% and 1.55%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?